Author

Anna C. Cooper

Observed name: Anna C. Cooper, PA-C

Institutions: Mayo Clinic, Mayo Clinic Comprehensive Cancer Center (Minnesota)

Observed institutions: Mayo Clinic, Mayo Clinic Comprehensive Cancer Center (Minnesota)

OpenAlex ID: A5054408689

A phase II study of pemetrexed and pembrolizumab in patients (pts) with recurrent and/or metastatic (R/M) salivary gland cancer (SGC): Results from non-adenoid cystic cohort.

2025 · Katharine Andress Rowe Price, Nathan R. Foster, et al. · Journal of Clinical Oncology · 1

Capecitabine for Salvage Treatment of Patients With Heavily Pretreated Human Papillomavirus–Associated Oropharynx Cancer With Distant Metastases

2023 · Anna C. Cooper, PA-C, Casey A. Fazer, PA-C, et al. · Journal of the Advanced Practitioner in Oncology · 1

A phase II study of pemetrexed and pembrolizumab in recurrent and/or metastatic salivary gland malignancies.

2022 · Katharine Andress Rowe Price, Nathan R. Foster, et al. · Journal of Clinical Oncology · 1

Epidemiology, clinical characteristics and outcomes of intracranial metastases (ICM) in human papillomavirus positive (HPV+) oropharyngeal squamous cell carcinoma (OPSCC).

2025 · Binav Baral, Ramesh Lamichhane, et al. · Journal of Clinical Oncology

Works count: 4

Citation count: 3

H-index: 1

I10-index: